Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote ()	2/15/1999 11:24:00 PM
From: Dave K	Read Replies (1) of 3158

The good news: Venture capital hasn't given up on the biotech sector. The better news: Venture capital's ideas about what kind of biotech companies to build are pretty well aligned with pharma's ideas about what kind of biotechs to fund. The best news: Venture capital is keeping a step or two ahead of pharma's alliance appetite. ....heavily back second generation genomics approaches... signalsmag.com Thoughts on how this VC angle might influence value of public bios ? Just Arrived Today... Consolidation -- Is it coming? signalsmag.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next